Blood sample analysis
Diagnostic TestAnalysis of proposed biomarkers.
NCT Number: NCT05665946
To investigate a number of blood based parameters in patients with intestinal ischaemia compared to patients with other acute abdominal diseases.
Looking for future studies?
Notify Me18 year–120 year
All sexes
Observational
Intestinal ischemia is a life-threatening condition defined by interrupted blood supply to the intestinal tissue. Primary and secondary ischemia is obstruction of blood-supply due to vascular and extra-vascular pathology, respectively.
Early diagnosis and treatment are critical to save the ischemic bowel. Clinical findings of secondary intestinal ischaemia are related to the underlying cause e.g. vomiting and palpable hernia. Abdominal computed tomography (CT) can effectively visualize the causes. In contrast, the diagnosis of primary intestinal ischemia is often delayed due to the absence of specific clinical findings. Primary intestinal ischemia is visualized with CT ateriography, revealing mesentery arterial obstruction. However, in the acute setting a non-arterial phase CT is often performed but the findings are unspecific in the early stages and the pattern of findings which could indicate primary ischemia are not well understood. In primary and secondary ischemia, standard blood-based parameters are inconsistently elevated and highly unspecific. Newer blood-based parameters such as D-lactate has been proposed as ischaemic markers. D-lactate is produced by bacteria in the bowel lumen and translocation through a damaged bowel wall makes it a potential marker of intestinal ischemia.
A case-control-study of all acute admitted patients with abdominal pain in Aalborg, Denmark in the mentioned time range. The sensitivity and specificity of potiential biomarkers in a blood sample at time of admission as a marker of intestinal ischaemia will be examined.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Analysis of proposed biomarkers.
Time frame: 2015-2019, Just after inclusion
Measurement of baseline level of D-lactate as a predictor of AIN
Time frame: 2015-2019, Just after inclusion
Measurement of baseline level of I-FABP as a predictor of AIN.
Time frame: 2015-2019, Just after inclusion
Measurement of baseline level of Endothelin-1 as a predictor of AIN
Time frame: 2015-2019, Just after inclusion
Measurement of baseline level of L-lactate as a predictor of AIN
Aalborg University Hospital
Other
Acute Intestinal Ischaemia: the Preoperative Diagnostic Approach
Acronym: AIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06365827
Acute Kidney Injury, Acute Mesenteric Ischemia
Giessen, Hesse, Germany
View Trial DetailsNCT06507423
Acute Mesenteric Ischemia, Digestive Inflammation
Nancy, Lorraine, France
View Trial DetailsNCT05706012
Acute Mesenteric Ischemia, Digestive System Diseases
Leuven, Belgium
View Trial DetailsNCT05218863
Acute Mesenteric Ischemia
Tallinn, Estonia
View Trial Details